Helping the Released Guardian: Drug Combinations for Supporting the Anticancer Activity of HDM2 (MDM2) Antagonists

by Justyna Kocik, Monika Machula, Aneta Wisniewska, Ewa Surmiak, Tad A. Holak, Lukasz Skalniak
Published 2019-07-01

Germacranolides from <i>Carpesium divaricatum</i>: Some New Data on Cytotoxic and Anti-Inflammatory Activity

by Natalia Kłeczek, Janusz Malarz, Barbara Gierlikowska, Łukasz Skalniak, Agnieszka Galanty, Anna K. Kiss, Anna Stojakowska
Published 2021-07-01

Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation of p53-Mutated Cells

by Lukasz Skalniak, Justyna Kocik, Justyna Polak, Anna Skalniak, Monika Rak, Agnieszka Wolnicka-Glubisz, Tad A. Holak
Published 2018-10-01

CA-170 – A Potent Small-Molecule PD-L1 Inhibitor or Not?

by Bogdan Musielak, Justyna Kocik, Lukasz Skalniak, Katarzyna Magiera-Mularz, Dominik Sala, Miroslawa Czub, Malgorzata Stec, Maciej Siedlar, Tad A. Holak, Jacek Plewka
Published 2019-08-01

Human and mouse PD-L1: similar molecular structure, but different druggability profiles

by Katarzyna Magiera-Mularz, Justyna Kocik, Bogdan Musielak, Jacek Plewka, Dominik Sala, Monika Machula, Przemyslaw Grudnik, Malgorzata Hajduk, Marcin Czepiel, Maciej Siedlar, Tad A. Holak, Lukasz Skalniak
Published 2021-01-01